Obesity, insulin resistance and cancer risk

被引:70
作者
Jee, SH
Kim, HJ
Lee, J
机构
[1] Yonsei Univ, Grad Sch Publ Hlth, Dept Epidemiol & Hlth Promot, Seoul 120752, South Korea
[2] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD USA
[3] Eulji Univ, Sch Med, Dept Family Med, Seoul, South Korea
关键词
obesity; insulin resistance; cancer; mechanism;
D O I
10.3349/ymj.2005.46.4.449
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Obesity is a known cause of metabolic syndrome which includes Type 11 diabetes, hypertension, and dyslipidemia. it is well documented that insulin resistance contributes to the mortality and the incidence of metabolic syndromes including central obesity, dyslipidemia, hyperglycemia and hypertension. Both obesity and diabetes are emerging topics for researchers to consider as having a possible causal association with cancer since the two factors have been viewed as risk factors for cancer. The present paper introduced the hypothesis of a possible causal relationship between obesity, insulin resistance and cancer and reviews relevant existing studies in this area. More efforts and studies are needed to clarify the mechanisms and the common risk factors which might be incorporated into interventions to prevent cancer and cardiovascular diseases as top causes of death.
引用
收藏
页码:449 / 455
页数:7
相关论文
共 37 条
[1]   Overweight, obesity and cancer: Epidemiological evidence and proposed mechanisms [J].
Calle, EE ;
Kaaks, R .
NATURE REVIEWS CANCER, 2004, 4 (08) :579-591
[2]   Recovery of growth hormone release from suppression by exogenous insulin-like growth factor I (IGF-I): Evidence for a suppressive action of free rather than bound IGF-I [J].
Chapman, IM ;
Hartman, ML ;
Pieper, KS ;
Skiles, EH ;
Pezzoli, SS ;
Hintz, RL ;
Thorner, MO .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1998, 83 (08) :2836-2842
[3]   The effect of hypertension on the risk for kidney cancer in Korean men [J].
Choi, MY ;
Jee, SH ;
Sull, JW ;
Nam, CM .
KIDNEY INTERNATIONAL, 2005, 67 (02) :647-652
[4]   Hyperglycemia, obesity, and cancer risks on the horizon [J].
Cooney, KA ;
Gruber, SB .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2005, 293 (02) :235-236
[5]   Metabolic syndrome - A comprehensive perspective based on interactions between obesity, diabetes, and inflammation [J].
Dandona, P ;
Aljada, A ;
Chaudhuri, A ;
Mohanty, P ;
Garg, R .
CIRCULATION, 2005, 111 (11) :1448-1454
[6]   The anti-inflammatory and potential anti-atherogenic effect of insulin: a new paradigm [J].
Dandona, P ;
Aljada, A ;
Mohanty, P .
DIABETOLOGIA, 2002, 45 (06) :924-930
[7]  
Furukawa S, 2004, J CLIN INVEST, V114, P1752, DOI [10.1172/JCI21625, 10.1172/JCI20042162S]
[8]   Obesity and coronary heart disease [J].
Garrison, RJ ;
Higgins, MW ;
Kannel, WB .
CURRENT OPINION IN LIPIDOLOGY, 1996, 7 (04) :199-202
[9]   INSULIN AND COLON-CANCER [J].
GIOVANNUCCI, E .
CANCER CAUSES & CONTROL, 1995, 6 (02) :164-179
[10]   Serum levels of leptin, insulin, and lipids in relation to breast cancer in China [J].
Han, CZ ;
Zhang, HT ;
Du, LL ;
Liu, XY ;
Jing, JX ;
Zhao, XW ;
Yang, X ;
Tian, BG .
ENDOCRINE, 2005, 26 (01) :19-24